MedTrace Logo

Changes in Prostaglandin Levels in Laser Cataract Surgery (LCS) Subject to Laser Prevalence

NCT03390400 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-03-02

No results posted yet for this study

Summary

The investigational device is an approved femtosecond laser (FSL) device with an integrated imaging system to perform certain steps of the cataract procedure. The FSL will perform anterior capsulotomy and lens fragmentation in individuals suffering from age-related cataract with need of cataract surgery.

Cataract surgery will be performed in subjects who have signed an informed consent form. Aqueous humor will be collected and screening will be performed for Total Prostaglandin and Prostaglandin E2 via en-bloc Enzyme-linked Immunosorbent Assay (ELISA)-Kit.

Conditions

  • Age Related Cataracts

Interventions

DEVICE

Femtosecondlaser-assisted

Femtosecondlaser-assisted Cataract Surgery will be performed bilateral on the same day with different laser settings.

PROCEDURE

Anterior Capsulotomy

Cataract Surgery

PROCEDURE

Lens Fragmentation

Cataract Surgery

Sponsors & Collaborators

  • Rupert Menapace

    lead OTHER

Principal Investigators

  • Rupert Menapace, MD · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-29
Primary Completion
2018-01-02
Completion
2018-03-14

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390400 on ClinicalTrials.gov